3Denimis MandGrasela D. Clinical pharmacoloy of gatifloxacin, a new fluoroquinolone [J]. Clin Infect Dis,2000,31 (Supply2) : 51. 被引量：1
4Piddock L V, Johnson M, Ricci V, et al. Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract []. Antimicrob Agents Chemother, 1998,42 (11 ) : 2956. 被引量：1
5Wakabayashi E, Mitsuhashi S. In vitro antibacterial activity of AM-1155, a novel 6-fluoro-8-methoxy quinolone [J]. Antimicrob Agents Chemother, 1994,38 (3) : 594. 被引量：1
6Banernfeind A. Comparison of the antibacterial activities of the quinolones Bay12-8039, gatifloxacin (AM1155),trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [J]. J Antimicrob Chemother, 1997,40:639. 被引量：1
7Li Q,Dunn E T,Grandmaison E W,et al.Applications of chitin and chitosan[M].Technomic Co Inc,1997.2-21. 被引量：1
8Charles Brine J.Advances in chitin and chitosan[M].Elsevier Applied Science,1992.2-15. 被引量：1
9Thomas C,Chandra P.Chitosan beads and granules for oral sustained delivery of nifedipine:in vitro studies[J].Biomaterials,1992,13:949-952. 被引量：1
10Jameela S R,Jayakrishnan A.Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle[J].Biomaterials,1995,16:769-775. 被引量：1
